- 全部删除
- 您的购物车当前为空
EP3 antagonist 3是一种有效和选择性的EP3拮抗剂,具有口服活性的优点,在自发性高血压大鼠(SHR)中显著抑制了GR63799或乙酸诱导的膀胱容量降低和PGE2诱导的过度活跃膀胱模型。
为众多的药物研发团队赋能,
让新药发现更简单!
EP3 antagonist 3是一种有效和选择性的EP3拮抗剂,具有口服活性的优点,在自发性高血压大鼠(SHR)中显著抑制了GR63799或乙酸诱导的膀胱容量降低和PGE2诱导的过度活跃膀胱模型。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,290 | In stock | |
5 mg | ¥ 2,430 | 5日内发货 | |
25 mg | ¥ 8,620 | 6-8周 | |
50 mg | ¥ 11,200 | 6-8周 | |
100 mg | ¥ 15,779 | 6-8周 | |
1 mL x 10 mM (in DMSO) | ¥ 2,470 | 5日内发货 |
产品描述 | EP3 antagonist 3, a potent and selective EP3 antagonist with the advantage of oral activity, significantly inhibited GR63799- or acetic acid-induced reduction in bladder capacity and PGE2-induced overactive bladder model in spontaneously hypertensive rats (SHR). |
靶点活性 | EP3:8.3 (pKi) |
分子量 | 362.38 |
分子式 | C21H18N2O4 |
CAS No. | 1227827-88-4 |
Smiles | O=C1OC(C(=O)N1)(C2=CC=C(NC2=O)C=3C=CC=4C=CC=CC4C3)C(C)C |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 200 mg/mL (551.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容